We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us


EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecula... read more Featured Products: More products

Download Mobile App

Antiphospholipid Antibodies Evaluated in Autoimmune Thyroid Diseases

By LabMedica International staff writers
Posted on 29 Nov 2022
Print article
Image: Antiphospholipid Antibodies Evaluated in Autoimmune Thyroid Diseases (Photo courtesy of VisitHealth limited)
Image: Antiphospholipid Antibodies Evaluated in Autoimmune Thyroid Diseases (Photo courtesy of VisitHealth limited)

Autoimmune thyroid diseases (AITD) is the most common organ-specific autoimmune disease, mainly caused by genetic predisposition, environmental factors and dysfunction in the microbiome.

The main types of AITD are Hashimoto's thyroiditis (HT) and Graves' disease (GD). HT, considered the most common endocrine disorder, is characterized by invasion of the thyroid gland by inflammatory lymphocyte cells. This infiltration induced the destruction and the replacement of follicular tissue leading to hypothyroidism.

Immunologists at the Farhat Hached Hospital (Sousse, Tunisia) carried out a retrospective study that included 195 AITD patients. The inclusion criteria were patients older than 18 years and suffering from HT or GD. Patients with another autoimmune disease associated to AITD were excluded. Sera were consecutively collected between January 2017 and December 2018 from four hospitals in the center of Tunisia. Ninety age-matched healthy blood donors (HBD) served as a control group.

Anti-cardiolipin antibodies (aCL, (IgG, IgA and IgM) were determined by using an enzyme-linked immunosorbent assay (ELISA) (Orgentec Diagnostika, Mainz, Germany). Anti-β2 glycoprotein I antibodies (aβ2GPI, IgG, IgA and IgM) were evaluated by an ELISA (Orgentec Diagnostika) using highly purified human β2GPI. Anti-thyroid peroxidase antibodies (TPO-Ab) and anti-thyroglobulin antibodies (Tg-Ab) were assessed with ELISA kit (Euroimmun, Lübeck, Germany). Human autoantibodies against thyrotropin (TSH) receptor (TRAb) were assessed with an ELISA kit (Euroimmun).

The investigators reported that 154 AITD patients were women and 41 were men. Fifty-six healthy subjects were women and 34 were men. The median age of patients and the control group was 45 and 38.5 years, respectively. The frequency of antiphospholipid (aPL) antibodies was significantly higher in patients with AITD and in patients with HT than in HBD (33.3% versus 11.1%, and 38.1% versus 11.1%). The frequency of aPL in GD was significantly lower than in HT (21.4% versus 38.1%). In patients with HT, aβ2GPI (34.5%) was significantly more frequent than aCL (13.6%). The frequency of aβ2GPI was significantly higher in patients with HT than in healthy population (34.5% versus 11.1%). In HT patients, IgA isotype of aβ2GPI was significantly more common than in healthy blood donors (HBD) and in GD patients (27.3% versus 7.8%, and 27.3% versus 12.5%).

The authors concluded that aβ2GPI and not aCL were frequent in AITD. IgA was the predominant isotype of aβ2GPI and that aβ2GPI-IgA was more frequent in HT than in GD. The study was published on November 25, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
Farhat Hached Hospital
Orgentec Diagnostika

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rickettsia Conorii Assay

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.